로딩 중…
지수 로딩 중…
NanoenTek,Inc.
039860· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩4,030-4.50%
2026-06-19
Price Chart
NanoenTek,Inc.+11.02%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 153.52B KRW |
| Revenue | 40.66B KRW |
| Net Income | 2.65B KRW |
| Total Assets | 100.68B KRW |
| Net Assets | 92.04B KRW |
| Employees | 138 |
| Value | |
| P/E | 57.87x |
| P/B | 1.67x |
| PEG | 0.20x |
| P/S | 3.78x |
| EV/EBITDA | 120.79x |
| FCF Yield | 0.76% |
| Profitability | |
| ROE | 2.88% |
| ROA | 2.64% |
| Op. Margin | 2.88% |
| Revenue Growth | 31.74% |
| Earnings Growth | 287.02% |
| Financial Health | |
| Debt Ratio | 109.38% |
| FCF | 1.16B KRW |
| Cash | 12.30B KRW |
| Current Ratio | 10.44x |
| Net Debt/EBITDA | -10.52x |
| Performance | |
| 1Y Return | 11.02% |
| 1M Return | -21.14% |
| From 52W High | -57.08% |
| 1Y MDD | -47.46% |
| Trading | |
| Volume | 266,431 shares |
| Foreign Own. | 1.25% |
| Per Share | |
| EPS | 76 KRW |
| BPS | 2,432 KRW |
Company Info
NanoEnTek, established in 1987 as an information security business and rebranded in 2006, is headquartered in Guro-gu, Seoul. The company, slated to become a subsidiary of AAI Healthcare in 2025, specializes in Lab-on-a-chip based in-vitro diagnostic devices and immunodiagnostic systems. Its FREND System has received FDA approval and is stably supplied in North America. Utilizing Bio-MEMS and microfluidic technology, NanoEnTek conducts precise clinical tests, holding 108 registrations and expanding its business globally.